GDC-0941 - ≥98%, high purity , PI3-kinase class I inhibitor, CAS No.957054-30-7, PI3-kinase class I inhibitor

Item Number

G126357

• Synonyms: s7808 | TXCWBWKVIZGWEQ-UHFFFAOYSA-N | HMS3244H10 | HMS3265J06 | Pictilisib [USAN:INN] | s1065 | Pictilisib (USAN) | Q27088388 | 4-[2-(1H-indazol-4-yl)-6-[(4-methylsulfonyl-1-piperazinyl)methyl]-4-thieno[3,2-d]pyrimidinyl]morpholine | DTXSID40241930 | EC-0
• Specifications & Purity: Moligand™, ≥98%
• Biochemical and Physiological Mechanisms: GDC-0941 is a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer. GDC-0941 against p110a IC50=0.003μM,U87MG IC50=0.95μM, A2780 IC50=0.14 μM, and in vitro metabolic stability in mouse and human is 91.96%. The
• Storage Temp: Store at -20°C
• Shipped In: Ice chest + Ice pads
• Grade: Moligand™
• Action Type: INHIBITOR
• Mechanism of action: PI3-kinase class I inhibitor
• Note: Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.

Product Description

Pictilisib (GDC-0941) is a potent inhibitor of PI3Kα/δ with IC50 of 3 nM in cell-free assays, with modest selectivity against p110β (11-fold) and p110γ (25-fold). Phase 2.
A potent inhibitor the PI 3-kinase family